Cwm, LLC Harvard Bioscience Inc Transaction History
Cwm, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Cwm, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Cwm, LLC holds 837 shares of HBIO stock, worth $1,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
837
Previous 436
91.97%
Holding current value
$1,372
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
31.4MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$4.66 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$4.55 Million0.44% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.72MShares$4.45 Million0.87% of portfolio
-
Amh Equity LTD2.39MShares$3.92 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$3.53 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $68.3M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...